These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2216751)

  • 1. Identification of a factor IX point mutation using SSCP analysis and direct sequencing.
    Demers DB; Odelberg SJ; Fisher LM
    Nucleic Acids Res; 1990 Sep; 18(18):5575. PubMed ID: 2216751
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP.
    Sarkar G; Yoon HS; Sommer SS
    Nucleic Acids Res; 1992 Feb; 20(4):871-8. PubMed ID: 1371869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-strand conformation polymorphism (SSCP) analysis of the molecular pathology of hemophilia B.
    David D; Rosa HA; Pemberton S; Diniz MJ; Campos M; Lavinha J
    Hum Mutat; 1993; 2(5):355-61. PubMed ID: 8257988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct carrier testing of haemophilia B by SSCP.
    Martinez PA; Romey MC; Schved JF; Gris JC; Demaille J; Claustres M
    Clin Lab Haematol; 1994 Mar; 16(1):15-20. PubMed ID: 7913672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic basis and carrier detection of hemophilia B of Chinese origin.
    Lin SW; Shen MC
    Thromb Haemost; 1993 Mar; 69(3):247-52. PubMed ID: 8470048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of factor IX mutations in Iranian haemophilia B patients by SSCP and sequencing.
    Karimipoor M; Zeinali S; Nafissi N; Tuddenham EG; Lak M; Safaee R
    Thromb Res; 2007; 120(1):135-9. PubMed ID: 17014892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor IX gene mutations causing haemophilia B: comparison of SSC screening versus systematic DNA sequencing and diagnostic applications.
    Aguilar-Martinez P; Romey MC; Schved JF; Gris JC; Demaille J; Claustres M
    Hum Genet; 1994 Sep; 94(3):287-90. PubMed ID: 8076946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new haemophilia BM case produced by a mutation located at the carboxy terminal cleavage site of activation peptide.
    Solera J; Magallón M; Martin-Villar J; Coloma A
    Br J Haematol; 1991 Jul; 78(3):385-9. PubMed ID: 1651755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdeletions in the factor IX gene: three recurrences associated with a quasipalindromic sequence.
    Ketterling RP; Sommer SS
    Hum Mol Genet; 1994 Jan; 3(1):191-2. PubMed ID: 8162024
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor IXBasel: a Swiss family with severe haemophilia B having a point mutation in EGF type B domain.
    Alkan M; Rodriguez Ponte M; Malik NJ; Hofmann S; Bösch-Al Jadooa N; Müller H; Bühler EM
    Nucleic Acids Res; 1991 Jan; 19(2):409. PubMed ID: 2014182
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients.
    Nielsen LR; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 1995 May; 73(5):774-8. PubMed ID: 7482402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of twenty-one new mutations in the factor IX gene by SSCP analysis.
    Montejo JM; Magallón M; Tizzano E; Solera J
    Hum Mutat; 1999; 13(2):160-5. PubMed ID: 10094553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B.
    Vielhaber E; Jacobson DP; Ketterling RP; Liu JZ; Sommer SS
    Hum Mol Genet; 1993 Aug; 2(8):1309-10. PubMed ID: 8401514
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new polymorphism in the human factor IX gene, useful for determining carriers of hemophilia B].
    Surin VL; Luk'ianenko AV; Tagiev AF; Smirnova OV
    Genetika; 1994 Jun; 30(6):740-2. PubMed ID: 7958786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five novel factor IX mutations in unrelated hemophilia B patients.
    David D; Moreira I; Morais S; de Deus G
    Hum Mutat; 1998; Suppl 1():S301-3. PubMed ID: 9452115
    [No Abstract]   [Full Text] [Related]  

  • 17. Five novel factor IX mutations in unrelated hemophilia B families.
    Chen SH; Schoof JM; Scott CR; Thompson AR
    Hum Mol Genet; 1993 May; 2(5):599-600. PubMed ID: 8518801
    [No Abstract]   [Full Text] [Related]  

  • 18. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype).
    Reitsma PH; Mandalaki T; Kasper CK; Bertina RM; Briët E
    Blood; 1989 Feb; 73(3):743-6. PubMed ID: 2917196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor IX mutations: rapid, direct screening methods for 20 new families with hemophilia B.
    Thompson AR; Schoof JM; Weinmann AF; Chen SH
    Thromb Res; 1992 Jan; 65(2):289-95. PubMed ID: 1579901
    [No Abstract]   [Full Text] [Related]  

  • 20. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
    Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
    Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.